Journal
CANCER LETTERS
Volume 283, Issue 1, Pages 20-28Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2009.03.021
Keywords
Gene therapy; Radiation tolerance; hTERT promoter; HRP/IAA; Laryngeal squamous cell carcinoma
Categories
Funding
- National Natural Science Foundation of China [30672438]
- Hubei Provincial Natural Science Foundation of China [2004ABA165, 2006ABC009]
Ask authors/readers for more resources
Radioresistant cells have been shown to correlate with poor outcome after radiotherapy. Here, we found that human telomerase reverse transcriptase promoter (hTERTp) had lower activity in laryngeal squamous carcinomas cells than in radioresistant variant cells. Combining radiotherapy with plasmid phTERTp-HRP, in which expression of enzyme horseradish peroxidase (HRP) controlled by hTERTp, resulted in increased apoptosis and necrosis of tumor cells after prodrug indole-3-acetic acid (IAA; converted by HRP into a cytotoxin) incubation. Volume and wet weight of xenograft tumor were reduced more in the combination groups. These data suggest that hTERTp has potential use in targeted cancer gene therapy, especially for radioresistant tumors. Combining radiotherapy with hTERTp-HRP/IAA may overcome radioresistance in laryngeal squamous carcinomas cells and amplify the killing effect in targeted cancer cells. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available